Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.12 and traded as high as $8.51. Predictive Oncology shares last traded at $8.04, with a volume of 110,759 shares trading hands.
Predictive Oncology Price Performance
The business has a 50 day moving average price of $7.49 and a 200 day moving average price of $5.15. The firm has a market capitalization of $28.07 million, a P/E ratio of -0.61 and a beta of 1.35.
About Predictive Oncology
Predictive Oncology, Inc is a biotechnology company that leverages artificial intelligence and digital biology to support drug discovery and development in oncology. Its core business revolves around the application of machine learning algorithms to high-content cellular imaging, multi-omic profiling, and clinical response data. By integrating these diverse data streams, the company aims to generate predictive models that forecast the efficacy and toxicity of candidate therapeutics, thereby accelerating preclinical decision-making and reducing development timelines.
The company’s primary offerings include its Phenomics platform, which combines automated microscopy with advanced image analysis to capture subtle phenotypic changes in cancer cells.
Further Reading
- Five stocks we like better than Predictive Oncology
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
